Skip to content
DataLookout
Menu

UNI-PFANCT07926854

Unipolar Voltage-Guided Substrate Modification Plus Pulsed Field Ablation Pulmonary Vein Isolation Versus Pulmonary Vein Isolation Alone in Persistent Atrial Fibrillation

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Treatment Success at 12 Months After the Index Ablation Procedure
Timeframe: 12 months after the index ablation procedure

Secondary (12)

Time to First Recurrence After a Single Procedure Off Antiarrhythmic Drugs
Change in AFEQT Quality-of-Life Score From Baseline to 12 Months
Incidence of Prespecified Procedure-Related Complications
Freedom From Atrial Arrhythmia at 12 Months After a Single Procedure Off Antiarrhythmic Drugs
Freedom From Atrial Arrhythmia at 12 Months After a Single Procedure With or Without Antiarrhythmic Drugs
Show 7 moreShow less
Freedom From Atrial Arrhythmia at 12 Months After 1-2 Procedures With or Without Antiarrhythmic Drugs
Freedom From Atrial Fibrillation at 12 Months After 1-2 Procedures Off Antiarrhythmic Drugs
Atrial Arrhythmia Burden at 3, 6, and 12 Months
Time to First Recurrence After Any Number of Procedures
Number of Repeat Ablations Within 12 Months
Procedure Duration
Total Fluoroscopy Time

Arms and interventions

PFA-PVI Plus Individualized Substrate ModificationExperimental

Pulsed field ablation (PFA)-based pulmonary vein isolation plus unipolar voltage-guided individualized substrate modification. Substrate modification is selected according to low-voltage area location and may include homogenization, box isolation, linear ablation, or a combination.

PFA-PVI AloneActive comparator

Pulsed field ablation (PFA)-based pulmonary vein isolation alone, without substrate or prophylactic ablation.

Devices: VARIPULSE Pulsed Field Ablation System

Procedures: Pulmonary Vein Isolation, Individualized Substrate Modification

Sites

1 site in 1 country

  • Fuwai Hospital, Chinese Academy of Medical SciencesBeijing, Beijing Municipality, China